Earlier, the Russian Direct Investment Fund (RDIF) and TopRidge Pharma (China’s Tibet Rhodiola Pharmaceutical Holding subsidiary) agreed to produce more than 100 million Sputnik V doses in China yearly
Earlier, the Russian Direct Investment Fund (RDIF) and TopRidge Pharma (China’s Tibet Rhodiola Pharmaceutical Holding subsidiary) agreed to produce more than 100 million Sputnik V doses in China yearly
